PAREXEL Expands Global Clinical Pharmacology Ca...(est such facility in the region. The uni...),Health

The PAREXEL Clinical Pharmacology Research Unit in London, established more than 15 years ago, has been expanded to a 64-bed capacity. The unit has experience with all types of Phase I studies, including pharmacokinetic and pharmacodynamic studies, and has the ability to conduct PET studies, as well. Clinical pharmacology experts based in the London unit have experience across a broad range of therapeutic areas, with extensive expertise in conducting cardiology and respiratory studies. The unit has a dedicated respiratory laboratory, and is outfitted with cardiac telemetry and electrocardiogram (ECG) monitoring.

PAREXEL has two long-established Clinical Pharmacology Research Units in Berlin. With the recent expansion, the units now have 160 total beds. The two sites have dedicated medical teams that utilize identical equipment and systems to assure harmonized procedures and workflow. The units have sleep research capabilities and a sleep laboratory, as well as extensive expertise in cardiovascular, central nervous system, respiratory, dermatology, metabolism and endocrine, and infectious disease studies.

In addition to the units noted above, PAREXEL also has clinical pharmacology research units in San Diego and Los Angeles in the United States, and in Bloemfontein and George, South Africa. PAREXEL also provides early clinical development programs through a joint venture arrangement with Synchron Research based in India. The Company's northern and southern hemisphere locations provide seasonal benefits for year-round studies, as well as access to specialized patient populations and the ability to conduct multi- site studies for parallel clinical development. All
'/>"/>